| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1448 |
| Trial ID | NCT01853631 |
| Disease | Acute Monocytic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) |
| Year | 2014 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-31970 SAGAN|SAGAN |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||